Asset Management One’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-63,502
Closed -$1.61M 1037
2022
Q3
$1.61M Buy
63,502
+608
+1% +$21.3K 0.01% 782
2022
Q2
$2.09M Buy
62,894
+4,828
+8% +$205K 0.01% 762
2022
Q1
$4.19M Sell
58,066
-434
-0.7% -$31.3K 0.02% 673
2021
Q4
$5.28M Sell
58,500
-959
-2% -$115K 0.02% 648
2021
Q3
$7.54M Buy
59,459
+1,874
+3% +$273K 0.03% 550
2021
Q2
$9.57M Buy
57,585
+2,962
+5% +$480K 0.04% 490
2021
Q1
$9.93M Buy
54,623
+1,130
+2% +$262K 0.04% 465
2020
Q4
$10.6M Buy
53,493
+20,155
+60% +$4.1M 0.04% 419
2020
Q3
$7.31M Sell
33,338
-1,809
-5% -$383K 0.03% 478
2020
Q2
$6.71M Buy
+35,147
New +$6.16M 0.03% 482

Other funds holding TDOC

Asset Management One's TDOC Position: Q4 2022 in Review

Asset Management One sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 63,502 shares — an estimated $1.61M sold.

Asset Management One first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $10.6M in Q4 2020. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Asset Management One reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Asset Management One sold 63,502 Teladoc Health shares in Q4 2022, an estimated $1.61M.
  • Asset Management One first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • Asset Management One's Teladoc Health position peaked at $10.6M in Q4 2020.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Asset Management One's 13F filing for Q4 2022, filed 6 Feb 2023.